CD19+CD27-IGM+IGD+ (% Pos of B)

Optimal result: 58 – 78 %

Elevated production of Naive B Cells with the CD19+CD27-IgM+IgD+ phenotype indicates an increase in a specific subset of B cells in the immune system. Here's what it means:

  1. Naive B Cells: Naive B cells are a subset of B cells that have not encountered antigens (foreign substances like pathogens) and are in their "inexperienced" state.

  2. CD19, CD27, IgM, and IgD: These are surface markers on B cells used to categorize and identify different B cell subsets. In this context:

    • CD19 is a common B cell marker.
    • CD27 is often used to distinguish between memory and naive B cells.
    • IgM and IgD are immunoglobulins (antibodies) expressed on B cells, and their presence or absence can further categorize B cell subsets.
  3. Elevated Production: An increase in naive B cells with the CD19+CD27-IgM+IgD+ phenotype may suggest an overactive or abnormal immune response. It could be due to various factors, including infections, autoimmune diseases, or other immune system disorders.

  4. Clinical Implications: The clinical significance of elevated production of these B cells depends on the broader context of the individual's health, symptoms, and other diagnostic findings. It may require further evaluation by a healthcare professional to determine the underlying cause and appropriate management.

Note: An elevated production of naive B cells with the CD19+CD27-IgM+IgD+ phenotype suggests an alteration in the immune system, but a definitive interpretation and any necessary actions should be made in consultation with a medical expert, taking into account the individual's specific health condition and medical history.

Naive B cells, characterized as CD19+CD27-IGM+IGD+, are a subset of B cells that have not yet encountered an antigen. Here's a breakdown of their characteristics:

  • CD19+: This marker signifies that these cells express the CD19 antigen, which is a common B cell marker.

  • CD27-: Naive B cells lack CD27 expression. CD27 is a marker used to distinguish between memory B cells and naive B cells. The absence of CD27 indicates that these B cells have not undergone the differentiation and class-switching that typically occurs in memory B cells.

  • IGM+ and IGD+: Naive B cells express both IgM and IgD immunoglobulin isotypes on their surface. IgM and IgD are B cell receptors and are important for antigen recognition. Naive B cells carry both to allow them to respond to a wide range of antigens effectively.

Naive B cells, characterized as CD19+CD27-IGM+IGD+, are a subset of B cells that have not yet encountered an antigen. Here's a breakdown of their characteristics:

  • CD19+: This marker signifies that these cells express the CD19 antigen, which is a common B cell marker.

  • CD27-: Naive B cells lack CD27 expression. CD27 is a marker used to distinguish between memory B cells and naive B cells. The absence of CD27 indicates that these B cells have not undergone the differentiation and class-switching that typically occurs in memory B cells.

  • IGM+ and IGD+: Naive B cells express both IgM and IgD immunoglobulin isotypes on their surface. IgM and IgD are B cell receptors and are important for antigen recognition. Naive B cells carry both to allow them to respond to a wide range of antigens effectively.

CD19+CD27-IGM+IGD+ (% Pos of B)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond CD19+CD27-IGM+IGD+ (% Pos of B) — 10,000+ markers explained
One CD19+CD27-IGM+IGD+ (% Pos of B) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro